Compliance with Pregnancy Prevention Recommendations for Isotretinoin Following the Amendment of the European Union Pregnancy Prevention Program: A Repeat Study in Estonia
Abstract Background Isotretinoin, indicated for severe acne, is a potent teratogen and therefore contraindicated in pregnancy. Thus, the pregnancy prevention program (PPP) for isotretinoin has been introduced. Objectives The aim of this study was to assess the concomitant use of isotretinoin and eff...
Sábháilte in:
Príomhchruthaitheoirí: | Maaja Ivask (Údar), Katrin Kurvits (Údar), Maia Uusküla (Údar), Anne Juppo (Údar), Ott Laius (Údar), Mia Siven (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Adis, Springer Healthcare,
2023-07-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Trends in opioid prescribing in Estonia (2011‐2017)
de réir: Anneli Uusküla, et al.
Foilsithe / Cruthaithe: (2020) -
The COVID-19 pandemic and the use of benzodiazepines and benzodiazepine-related drugs in Estonia: an interrupted time-series analysis
de réir: Katrin Kurvits, et al.
Foilsithe / Cruthaithe: (2024) -
Non-compliance with pregnancy prevention recommendations for isotretinoin in Korea between 2019-2020
de réir: Eun Jeong Choi, et al.
Foilsithe / Cruthaithe: (2021) -
IMPACT OF JUDO RULES AMENDMENTS OVER TRAUMA PREVENTION
de réir: CHIRAZI Marin
Foilsithe / Cruthaithe: (2020) -
Isotretinoin; A review on the Utilization Pattern in Pregnancy
de réir: Sajad Khiali, et al.
Foilsithe / Cruthaithe: (2018)